COMPANY PROFILE

AMPLY Discovery

Explore full profile

Novel Biologics. Designed by Evolution. Discovered by AI

Belfast, United KingdomFounded 2021Biotech & Life Sciences

Valuation $5–10M Last recorded · 2025

Revenue <$1M Latest reported FY

Headcount <100 Current team size

Total funding $0–10M Disclosed equity funding

Unlock exact values

About AMPLY Discovery

Novel Biologics. Designed by Evolution. Discovered by AI.

Read full description

AMPLY Discovery uses machine learning and synthetic biology to mine vast biological data to discover novel biologic drug and nutraceutical candidates. Using a proprietary in silico and in vitro hybrid platform to discover best-in-class molecules AMPLY is helping tackle some of humankind's greatest challenges such as cancer, MDR infections and metabolic diseases.

Based in Belfast, Northern Ireland. Spin out from Queen's University Belfast.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2021
Headquarters: Belfast, United Kingdom
Employees: 7
Open positions: None listed
Dealroom signal: 76.3/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Medical Research, Drug Development, Genetics and genomics, Core AI, Spinout, Genome Engineering, Tech for Biotech and Pharma
Technology: Artificial Intelligence, Deep Tech
Business model: SaaS
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

8 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
EARLY VC✓Equity / VC	Jan 2026	$0	—	KPS Inc.	↗
SEED✓Equity / VC	May 2025	$1.7M	$6.9M	Undisclosed	↗

Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth
2026
2025
2024
2023
2022		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

AMPLY Discovery website traffic

Latest recorded traffic for AMPLY Discovery is 1.3K monthly website visits, up 8.3% over the last three months. AMPLY Discovery's team grew 16.7% over the past year.

Latest monthly visits1.3K 3-month web change+8.3% 1-year team growth+16.7%

Monthly website visitsNov 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
PHPharmEnablePharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery	Cambridge, United Kingdom	Operational	11	$16M	$30M
CHChemifyDigitizing chemistry by developing technology to convert chemical code into molecules and vice versa	Glasgow, United Kingdom	Operational
NTNucleome TherapeuticsDecoding the dark matter of the human genome to discover first-in-class precision medicine	Oxford, United Kingdom	Operational
ARArctorisArctoris is the world's first fully-automated drug discovery data engine, generating valuable insights for biotech and pharma partners	Oxford, United Kingdom	Operational
DEDeepMatterMedical research and development services	Glasgow, United Kingdom	Operational
HEHealxAI-drug discovery accelerating treatments for rare diseases	Cambridge, United Kingdom	Operational
EXExscientiaApplying artificial intelligence and big data processing to accelerate discovery and development of drugs	Oxford, United Kingdom	Acquired
OLOutsee limitedDeveloping and applying innovative computational approaches to genomics for drug target discovery and precision medicine	Cambridge, United Kingdom	Operational